Teva begins US shipments of generic Effexor XR per 2006 settlement
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical Industries began shipments of a generic version of Pfizer's extended-release venlafaxine product, Effexor XR capsules, on 1 July, for the treatment of major depressive disorder, following final approval of its ANDA from the US FDA in late June. The brand product has annual US sales of about $2.7 billion based on IMS sales data.